Common variants for atrial fibrillation: results from genome-wide association studies
- 553 Downloads
Atrial fibrillation (AF) affects more than 5 million people worldwide; however, none of the anti-arrhythmic drugs available now are entirely optimal in terms of efficacy and safety. A better understanding of the molecular mechanism of AF will facilitate the process of finding new strategies to prevent AF. As the non-familial AF is the major form of AF, identifying common variants for AF in these populations by genome-wide association studies will definitely accelerate this process. This review summarizes the recently identified common AF variants on 4q25, 16q22, and 1q21 and discusses their implications for the clinic.
- Chinchilla A, Daimi H, Lozano-Velasco E et al (2011) Pitx2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet 4:269–279Google Scholar
- Virani SS, Brautbar A, Lee W et al (2011) Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol 107:1505–1509Google Scholar
- Xiao JJ, Liang DD, Chen YH (2011) The genetics of atrial fibrillation: from the bench to the besides. Annu Rev Genomics Hum Genet 12:6.1–6.24Google Scholar
- Xiao J, Liang D, Zhang Y, et al. (2011) MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 43:655–664Google Scholar
- Zhang DF, Liang B, Lin J, Liu B, Zhou QS, Yang YQ (2005) KCNE3 R53H substitution in familial atrial fibrillation. Chin Med J (Engl) 118:1735–1738Google Scholar